A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
Clinical trial NCT03631186 · COMPLETED
Trial details
- NCT number
- NCT03631186
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-12
- Primary completion
- 2019-12-18
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.